https://www.selleckchem.com/pr....oducts/vls-1488-kif1
Atrial fibrillation (AF) is the most common arrhythmia affecting more than six million people in the United States. The economic burden is estimated to be $6 billion annually with catastrophic events dramatically increasing expenditure. When patients experience symptoms, they commonly present to an acute care facility; this can be costly and anxiety provoking. Same-day access issues prohibit patients from communicating directly with their cardiology provider, forcing them to use resources and increasing psychological bu
Like
Comment
Share
